Cargando…
Two-dimensional speckle tracking echocardiography help identify breast cancer therapeutics–related cardiac dysfunction
BACKGROUND: Cancer therapeutics–related cardiac dysfunction (CTRCD) from different chemotherapy strategies are underdetermined by echocardiography. As an imaging marker of subclinical cardiac dysfunction, two-dimensional speckle tracking echocardiography (2D-STE) may assist in identifying the impact...
Autores principales: | Liu, Wei, Li, Wei, Li, Hairu, Li, Ziyao, Zhao, Peng, Guo, Zihong, Liu, Cong, Sun, Litao, Wang, Zhenzhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9753263/ https://www.ncbi.nlm.nih.gov/pubmed/36522712 http://dx.doi.org/10.1186/s12872-022-03007-8 |
Ejemplares similares
-
Two-dimensional speckle tracking echocardiography in assessing the subclinical myocardial dysfunction in patients with gestational diabetes mellitus
por: Li, Wei, et al.
Publicado: (2022) -
Use of speckle tracking echocardiography in evaluating cardiac dysfunction in patients with acromegaly: an update
por: Huang, Rong, et al.
Publicado: (2023) -
Subclinical cardiac dysfunction in pediatric kidney transplant recipients identified by speckle-tracking echocardiography
por: Bárczi, Adrienn, et al.
Publicado: (2022) -
Cardiac Mechanics Evaluated by Speckle Tracking
Echocardiography
por: Abduch, Maria Cristina Donadio, et al.
Publicado: (2014) -
Cardiac Evaluation Using Two-Dimensional Speckle-Tracking Echocardiography and Conventional Echocardiography in Taiwanese Patients with Mucopolysaccharidoses
por: Lin, Hsiang-Yu, et al.
Publicado: (2020)